Jason Hawksworth MD, FACS (@jhawksworthmd) 's Twitter Profile
Jason Hawksworth MD, FACS

@jhawksworthmd

Transplant and Hepatobiliary Surgeon | Associate Professor | @ColumbiaMed

ID: 1122656839223713794

linkhttps://www.youtube.com/c/JasonHawksworthMD calendar_today29-04-2019 00:20:23

957 Tweet

4,4K Followers

3,3K Following

Iswanto Sucandy MD (@iswantosucandy) 's Twitter Profile Photo

Excellent Robotic Hepatobiliary Course during International Liver Transplantation Society in Houston organized by Dr. Cheah from Methodist. Excellent talks by Jason Hawksworth, Mathieu Dhondt, Gi Hong Choi, Caroline Simon and others. ILTS Intuitive AdventHealth AHPBA

Excellent Robotic Hepatobiliary Course during International Liver Transplantation Society in Houston organized by Dr. Cheah from Methodist. Excellent talks by Jason Hawksworth, Mathieu Dhondt, Gi Hong Choi, Caroline Simon and others.

<a href="/_ILTS_/">ILTS</a> <a href="/IntuitiveSurg/">Intuitive</a> <a href="/AdventHealth/">AdventHealth</a> <a href="/AHPBA/">AHPBA</a>
Sean Langenfeld (@seanlangenfeld) 's Twitter Profile Photo

Dr Jason Hawksworth MD, FACS is putting out some of the best surgical videos on social media. Innovative, well-edited, and informative enough that even a dumb butt doctor like me can understand a donor hepatectomy. He's definitely worth a follow!

ILLS (@ills_lapliver) 's Twitter Profile Photo

Who is coming to Japan along with them🤗?! We expect more and more participation and opinions from young & powerful #hpb surgeons to the discussion during #ILLS2024 in #Kyoto next October🇯🇵 🌍👩🏻‍⚕️🧑🏽‍⚕️👨🏼‍⚕️🌏 📩ABSTRACT SUBMISSION UNTIL MAY 31 🌟Visit: c-linkage.co.jp/ills-stc2024/

Who is coming to Japan along with them🤗?!

We expect more and more participation and opinions from young &amp; powerful #hpb surgeons to the discussion during  #ILLS2024 in #Kyoto next October🇯🇵

🌍👩🏻‍⚕️🧑🏽‍⚕️👨🏼‍⚕️🌏

📩ABSTRACT SUBMISSION UNTIL MAY 31

🌟Visit: c-linkage.co.jp/ills-stc2024/
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

CTx & liver transplantatison vs CTx in pts with unresectable CRC liver metastases at #ASCO24 🔎prospective trial TRANSMET, 94 pts 👉40% excluded, 9 drop out, 81% underwent LTx 👉mPFS 17.4 vs 6.4, 72% recurrence after LTx 👉5yr OS: 57% vs 13% 🧐potential cure for some pts,

CTx &amp; liver transplantatison vs CTx in pts with unresectable CRC liver metastases at #ASCO24
🔎prospective trial TRANSMET, 94 pts
👉40% excluded, 9 drop out, 81% underwent LTx
👉mPFS 17.4 vs 6.4, 72% recurrence after LTx
👉5yr OS: 57% vs 13%
🧐potential cure for some pts,
Kristopher Croome (@kriscroome) 's Twitter Profile Photo

Great Thomas E. Starzl lecture “What Organ Perfusion will do for Transplantation” AmericanTransplantCongress by Professor Peter Friend. Perfusion technologies #NMP #HMP #NRP are game changers in liver transplantation. Great points on what outcome measures we need to be studying. UTILIZATION

Great Thomas E. Starzl lecture “What Organ Perfusion will do for Transplantation” <a href="/ATCMeeting/">AmericanTransplantCongress</a> by Professor Peter Friend.
Perfusion technologies #NMP #HMP #NRP are game changers in liver transplantation. 

Great points on what outcome measures we need to be studying. UTILIZATION
Jason Hawksworth MD, FACS (@jhawksworthmd) 's Twitter Profile Photo

Hilar dissection during robotic living donor right hepatectomy. If you’re at #ATC2024 on Tuesday come to our Robotic Surgery in Transplantation event for more 🤖 videos! ASTS Columbia Surgery

Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

🔥news from #EASL2024 Liver transplantation following HCC downstaging with atezolizumab/bevacizumab: preliminary results of the ImmunoXXL study 👏still early, but amazing data 👉ICI before LTx seems feasible & safe 🧐Real chance to improve outcome in HCC EASL Education ESMO - Eur. Oncology

🔥news from #EASL2024
Liver transplantation following HCC downstaging with atezolizumab/bevacizumab: preliminary results of the ImmunoXXL study
👏still early, but amazing data
👉ICI before LTx seems feasible &amp; safe
🧐Real chance to improve outcome in HCC
<a href="/EASLedu/">EASL Education</a> <a href="/myESMO/">ESMO - Eur. Oncology</a>
NYC Transplant Hepatology (@nyc_tx_hep) 's Twitter Profile Photo

On Thursday, Columbia Medicine + Weill Cornell Medicine celebrated the graduation of 3 amazingly talented tx hep fellows. Excited to welcome Yael Nobel MD MS as a new faculty member + Dr. Sandeep Sikerwar to Columbia University's GI fellowship program. @Umiamimedicine is getting a ⭐️ in Dr. Gabe Perreault!

On Thursday, <a href="/ColumbiaMed/">Columbia Medicine</a> + <a href="/WeillCornell/">Weill Cornell Medicine</a>  celebrated the graduation of  3 amazingly talented tx hep fellows. Excited to welcome <a href="/yael_nobel/">Yael Nobel MD MS</a> as a new faculty member + Dr. Sandeep Sikerwar to <a href="/Columbia/">Columbia University</a>'s GI fellowship program. @Umiamimedicine is getting a ⭐️ in Dr. Gabe Perreault!
Riccardo Memeo (@dr_memeor) 's Twitter Profile Photo

(LAP)Winter is coming? ❄ ☃ ❄ 🗞ROB VS LAP Liver Resection in Various Settings 📑 Annals of Surgery 2024 🤖 Robotic: 💎 Higher rates of textbook outcomes 👑 Less Pringle, blood loss, transfusion, conversion ☠ Less Morbidity 💀 Less R1 🧙‍♂️ Short OT 📑acesse.dev/FQC6U

(LAP)Winter is coming? ❄ ☃ ❄ 
🗞ROB VS LAP Liver Resection in Various Settings
📑 Annals of Surgery 2024

🤖 Robotic:
💎 Higher rates of textbook outcomes
 👑 Less Pringle, blood loss, transfusion, conversion
☠ Less Morbidity
💀 Less R1
🧙‍♂️ Short OT
📑acesse.dev/FQC6U
Jason Hawksworth MD, FACS (@jhawksworthmd) 's Twitter Profile Photo

Incredible presentation of this data at #SRS2024 by Dr. Broering. Improved donor - and recipient! - outcomes with robotic living donor hepatectomy.

Incredible presentation of this data at #SRS2024 by Dr. Broering. Improved donor - and recipient! - outcomes with robotic living donor hepatectomy.
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

CTx & liver transplantation vs CTx alone in definitively unresectable CRC liver metastases #ESMOGI24 🔎Updates TRANSMET trial, 94 pts 👉Rigorous Pts selection is key! 👉57% 5-yr OS, HR 0.37 👉acceptable safety 🧐Supports LTx as one "new" option in CRC #ESMOAmbassadors ESMO - Eur. Oncology

CTx &amp; liver transplantation vs CTx alone in definitively unresectable CRC  liver metastases #ESMOGI24 
🔎Updates TRANSMET trial, 94 pts
👉Rigorous Pts selection is key!
👉57% 5-yr OS, HR 0.37
👉acceptable safety
🧐Supports LTx as one "new" option in CRC
#ESMOAmbassadors <a href="/myESMO/">ESMO - Eur. Oncology</a>
Iswanto Sucandy MD (@iswantosucandy) 's Twitter Profile Photo

We had the honor to organize and run the Hepatopancreatobiliary Session at Society of Robotic Surgery 2024 in Orlando FL. Excellent panels of Speakers in Liver, Pancreas and Transplantation specialities. New&innovative techniques were presented and these moved the needle forward.

We had the honor to organize and run the Hepatopancreatobiliary Session at Society of Robotic Surgery 2024 in Orlando FL. Excellent panels of Speakers in Liver, Pancreas and Transplantation specialities. New&amp;innovative techniques were presented and these moved the needle forward.
Mohamed Eltemamy (@moeltemamy) 's Twitter Profile Photo

Last week I was on call for kidney transplantation. We did 8 kidneys. 6 were robotic (including 4 from deceased donors). The landscape is rapidly shifting. American Journal of Transplantation ASTS Cleveland Clinic Urology #Robotics #Transplant #kidneytransplant #kidney #MedTwitter

Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

ITT outcomes of pts with HCC receiving immunotherapy before liver transplant Journal of Hepatology doi.org/10.1016/j.jhep… 🔎🇺🇸VITALITY study 👉86 pts 👉75.6% downstaged 👉36% LTx 👉3-year ITT OS 71.1% 👉 7 rejections, 1 graft lost 🧐More evidence to support ICI before LTx ESMO - Eur. Oncology

ITT outcomes of pts with HCC receiving immunotherapy before liver transplant
<a href="/JHepatology/">Journal of Hepatology</a> 
doi.org/10.1016/j.jhep…
🔎🇺🇸VITALITY study
👉86 pts
👉75.6% downstaged
👉36% LTx
👉3-year ITT OS 71.1%
👉 7 rejections, 1 graft lost
🧐More evidence to support ICI before LTx
<a href="/myESMO/">ESMO - Eur. Oncology</a>